COMPASS Pathways (CMPS) stock closes above $5.00 on 2026-08-10.

Predicted 2026-07-11 · Resolves 2026-08-10 · markets · USA

55%

ORACLE CONFIDENCE

✓ Came true

Every outcome is scored publicly in the ledger.

COMPASS Pathways is the leading publicly traded psilocybin drug development company, and its stock currently sits in uncertain territory. Whether it closes above $5.00 on August 10, 2026 is essentially a live read on whether investors still believe in the company's future. At roughly a coin-flip probability, this prediction reflects how genuinely uncertain the psychedelic biotech market is right now.

Resolution rule: YES if the closing price of COMPASS Pathways (NASDAQ: CMPS) on 2026-08-10 (or the most recent prior trading day if a holiday) is greater than $5.00. Checked via nasdaq.com / official closing price for CMPS. NO if it closes at or below $5.00.

Outcome evidence: Auto-resolved 2026-08-11 vs Yahoo daily closes. Predicted a close above $5.00; occurred on 2026-07-13 at $13.19. Confirmed.

Durability/relapse data remains the pivotal value driver for the leading psilocybin developer. Rather than an unfalsifiable 'durability remains pivotal' claim, a concrete near-term market-price check on the sector bellwether tests sentiment directly and resolves quickly.

5 new falsifiable predictions, every day at 12:05 PM ET.

Get tomorrow's Oracle →